Associate Director, Patient Impact, Orphan Disease Center, University of Pennsylvania; Co-Founder & Executive Director, Castleman Disease Collaborative Network
Dr. David Fajgenbaum, MD, MBA, MSc is Assistant Professor of Medicine at the University of Pennsylvania, co-founder/Executive Director of Castleman Disease Collaborative Network (CDCN), and a patient battling the same deadly disease--idiopathic multicentric Castleman disease (iMCD)--that he studies. He was diagnosed with iMCD during medical school. Between life-threatening relapses, Fajgenbaum created the CDCN, which is a model for international collaboration. He has published research that has changed the way iMCD is researched and treated. Currently, he is in his longest remission ever thanks to a precision treatment that he identified, which had never been used for iMCD.